Vitamin D Deficiency Increases the Risk for Moderate to Severe Disease Activity in Crohn's Disease Patients in South Africa, Measured by the Harvey Bradshaw Index

Journal of the American College of Nutrition

Volumn 35, Issue 2, 2016, Pages 163-174

  Raffner Basson, Abigail ^a   Swart, Rina ^a   Jordaan, Esme ^b,c   Mazinu, Mikatako ^c   Watermeyer, Gillian ^d,e  

^a Dietetics Department   (South Africa)

^b Statistics and Population Studies Department   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

25(OH)D; Crohn's disease; deficiency; Harvey Bradshaw Index; inflammatory bowel disease; South Africa; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASSESSMENT OF HUMANS; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HARVEY BRADSHAW INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT CONCENTRATION; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; COMPLICATION; MIDDLE AGED; SOUTH AFRICA;

ADULT; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SOUTH AFRICA; VITAMIN D DEFICIENCY;

EID: 84960219280     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2015.1039665     Document Type: Article

References (51)

1. M.T.Cantorna, Y.Zhu, M.Froicu, A.Wittke: Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80:S1717–S1720, 2004.
2. M.T.Cantorna, B.D.Mahon: D-hormone and the immune system. J Rheumatol 76:11–20, 2005.
3. M.T.Cantorna, B.D.Mahon: Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 229:1136–1142, 2004.
4. W.Lim, S.B.Hanauer, Y.C.Li: Mechanisms of disease: vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2:308–315, 2005.
5. M.Froicu, V.Weaver, T.A.Wynn, M.A.McDowell, J.E.Welsh, M.T.Cantorna: A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17:2386–2392, 2003.
6. M.T.Cantorna, C.Munsick, C.Bemiss, B.D.Mahon: 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130:2648–2652, 2000.
7. C.J.Bemiss, B.D.Mahon, A.Henry, V.Weaver, M.T.Cantorna: Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system. Arch Biochem Biophys 402:249–254, 2002.
8. R.Kühn, J.Löhler, D.Rennick, K.Rajewsky, W.Müller: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263–274, 1993.
9. B.D.Mahon, A.Wittke, V.Weaver, M.T.Cantorna: The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932, 2003.
10. M.Tajika, A.Matsuura, T.Nakamura, T.Suzuki, A.Sawaki, T.Kato, K.Hara, K.Ookubo, K.Yamao, M.Kato: Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol 39:527–533, 2004.
11. A.Joseph, B.George, A.Pulimood, M.Seshadri, A.Chacko: 25(OH) vitamin D level in Crohn's disease: association with sun exposure & disease activity. Ind J Med Res 130:133–137, 2009.
12. S.P.Jørgensen, C.L.Hvas, J.Agnholt, L.A.Christensen, L.Heickendorff, J.F.Dahlerup: Active Crohn's disease is associated with low vitamin D levels. J Crohns Colitis 7:e407–e413, 2013.
13. S.P.Jørgensen, J.Agnholt, H.Glerup, S.Lyhne, G.E.Villadsen, C.L.Hvas, L.E.Bartels, J.Kelsen, L.A.Christensen, J.F.Dahlerup: Clinical trial: vitamin D3 treatment in Crohn's disease—a randomized double‐blind placebo‐controlled study. Aliment Pharmacol Ther 32:377–383, 2010.
14. A.N.Ananthakrishnan, H.Khalili, L.M.Higuchi, Y.Bao, J.R.Korzenik, E.L.Giovannucci, J.M.Richter, C.S.Fuchs, A.T.Chan: Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 142:482–489, 2012.
15. A.N.Ananthakrishnan, A.Cagan, V.S.Gainer, T.Cai, S.Cheng, G.Savova, P.Chen, P.Szolovits, Z.Xia, P.L.De Jager: Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis 19:1921–1927, 2013.
16. M.Ham, M.S.Longhi, C.Lahiff, A.Cheifetz, S.Robson, A.C.Moss: Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment. Inflamm Bowel Dis 20:856–860, 2014.
17. B.Tan, P.Li, H.Lv, Y.Li, O.Wang, X.P.Xing, J.M.Qian: Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease. J Dig Dis 15:116–123, 2014.
18. L.Yang, V.Weaver, J.P.Smith, S.Bingaman, T.J.Hartman, M.T.Cantorna: Therapeutic effect of vitamin D supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol 4:e33, 2013. doi: 10.1038/ctg.2013.1
19. Y.T.Fu, N.Chatur, C.Cheong-Lee, B.Salh: Hypovitaminosis D in adults with inflammatory bowel disease: potential role of ethnicity. Dig Dis Sci 57:2144–2148, 2012.
20. J.R.de Bruyn, R.van Heeckeren, C.Y.Ponsioen, G.R.van den Brink, M.Lowenberg, A.J.Bredenoord, G.Frijstein, G.R.D'Haens: Vitamin D deficiency in Crohn's disease and healthy controls: a prospective case–control study in The Netherlands. J Crohns Colitis 8:1267–1278, 2014.
21. V.Hassan, S.Hassan, P.Seyed-Javad, K.Ahmad, H.Asieh, S.Maryam, F.Farid, A.Siavash: Association between serum 25 (OH) vitamin D concentrations and inflammatory bowel diseases (IBDs) activity. Med J Malaysia 68:35–38, 2013.
22. W.El-Matary, S.Sikora, D.Spady: Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci 56:825–829, 2011.
23. K.Vagianos, S.Bector, J.McConnell, C.N.Bernstein: Nutrition assessment of patients with inflammatory bowel disease. J Parenter Enteral Nutr 31:311–319, 2007.
24. G.P.Kini, B.Young, P.Herbison, M.Schultz: Does seasonal level of serum 25-OH vitamin D correlate with the activity of Crohn's disease? N Z Med J 127:51–59, 2014.
25. R.O'Neill, U.Mahadevan: Vitamin D status in inflammatory bowel disease: association with disease activity? Gastroenterology 140(5 Suppl 1):S–430, 2011.
26. A.Basson, R.Swart, E.Jordaan, M.Mazinu, G.Watermeyer: The association between race and Crohn's disease phenotype in the Western Cape population of South Africa, defined by the Montreal classification system. PloS One 9:e104859, 2014.
27. A.Basson, R.Swart, E.Jordaan, M.Mazinu, G.Watermeyer: The association between childhood environmental exposures and the subsequent development of Crohn's disease in the Western Cape, South Africa. PloS One 9:e115492, 2014.
28. G.Van Assche, A.Dignass, B.Bokemeyer, S.Danese, P.Gionchetti, G.Moser, L.Beaugerie, F.Gomollón, W.Häuser, K.Herrlinger: Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7:1–33, 2013.
29. M.S.Silverberg, J.Satsangi, T.Ahmad, I.Arnott, C.N.Bernstein, S.R.Brant, R.Caprilli, J.Colombel, C.Gasche, K.Geboes: Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5–36, 2005.
30. D.Epstein, G.Watermeyer, R.Kirsch: Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther 25:1373–1388, 2007.
31. M.F.Holick, N.C.Binkley, H.A.Bischoff-Ferrari, C.M.Gordon, D.A.Hanley, R.P.Heaney, M.H.Murad, C.M.Weaver: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 96:1911–1930, 2011.
32. World Health Organization: The UV index worldwide, 2013. Accessed at: http://www.who.int/uv/intersunprogramme/activities/uv_index/en/index3.html
33. A.Ulitsky, A.N.Ananthakrishnan, A.Naik, S.Skaros, Y.Zadvornova, D.G.Binion, M.Issa: Vitamin D deficiency in patients with inflammatory bowel disease association with disease activity and quality of life. J Parenter Enteral Nutr 35:308–316, 2011.
34. R.Vieth: The pharmacology of vitamin D, including fortification strategies. In D.Feldman, F.Glorieux (eds): “Vitamin D.” 2nd ed. London: Elsevier, pp 995–1015, 2005.
35. A.Basson: Vitamin D and Crohn's disease in the adult patient: a review. J Parenter Enteral Nutr 38:438–458, 2013.
36. D.Haarburger, M.Hoffman, R.T.Erasmus, T.S.Pillay: Relationship between vitamin D, calcium and parathyroid hormone in Cape Town. J Clin Pathol 62:567–569, 2009.
37. J.A.George, S.A.Norris, H.E.van Deventer, J.M.Pettifor, N.J.Crowther: Effect of adiposity, season, diet and calcium or vitamin D supplementation on the vitamin D status of healthy urban African and Asian-Indian adults. Br J Nutr 112:590–599, 2014.
38. E.D.Daniels, J.M.Pettifor, C.M.Schnitzler, G.P.Moodley, D.Zachen: Differences in mineral homeostasis, volumetric bone mass and femoral neck axis length in black and white South African women. Osteoporos Int 7:105–112, 1997.
39. K.E.Charlton, D.Labadarios, C.J.Lombard, M.E.Louw: Vitamin D status of older South Africans. S Afr Med J 86:1406–1410, 1996.
40. K.E.Charlton, L.T.Bourne, K.Steyn, J.A.Laubscher: Poor nutritional status in older black South Africans. Asia Pac J Clin Nutr 10:31–38, 2001.
41. A.R.Martineau, S.Nhamoyebonde, T.Oni, M.X.Rangaka, S.Marais, N.Bangani, R.Tsekela, L.Bashe, V.de Azevedo, J.Caldwell, T.R.Venton, P.M.Timms, K.A.Wilkinson, R.J.Wilkinson: Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci USA 108:19013–19017, 2011.
42. H.S.Schaaf, E.D.Nel, N.Beyers, R.P.Gie, F.Scott, P.R.Donald: A decade of experience with Mycobacterium tuberculosis culture from children: a seasonal influence on incidence of childhood tuberculosis. Tuber Lung Dis 77:43–46, 1996.
43. J.M.Pettifor, F.P.Ross, L.Solomon: Seasonal variation in serum 25-hydroxycholecalciferol concentrations in elderly South African patients with fractures of femoral neck. Br Med J 1:826–827, 1978.
44. J.M.Pettifor, G.P.Moodley, F.S.Hough, H.Koch, T.Chen, Z.Lu, M.F.Holick: The effect of season and latitude on in vitro vitamin D formation by sunlight in South Africa. S Afr Med J 86:1270–1272, 1996.
45. M.C.Aldhous, J.Satsangi: The impact of smoking in Crohn's disease: no smoke without fire. Frontline Gastroenterol 1:156–164, 2010.
46. D.Y.Han, A.G.Fraser, P.Dryland, L.R.Ferguson: Environmental factors in the development of chronic inflammation: a case–control study on risk factors for Crohn's disease within New Zealand. Mutat Res 690:116–122, 2010.
47. G.Corrao, A.Tragnone, R.Caprilli, G.Trallori, C.Papi, A.Andreoli, M.Di Paolo, G.Riegler, G.P.Rigo, O.Ferrau, C.Mansi, M.Ingrosso, D.Valpiani: Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case–control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol 27:397–404, 1998.
48. S.Bridger, J.C.Lee, I.Bjarnason, J.E.Jones, A.J.Macpherson: In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut 51:21–25, 2002.
49. Z.A.Zator, S.M.Cantu, G.G.Konijeti, D.D.Nguyen, J.Sauk, V.Yajnik, A.N.Ananthakrishnan: Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-alpha therapy in inflammatory bowel diseases. J Parenter Enteral Nutr 38:385–391, 2014.
50. M.Verway, M.A.Behr, J.H.White: Vitamin D, NOD2, autophagy and Crohn's disease. Expert Rev Clin Immunol 6:505–508, 2010.
51. Received November 19, 2014; accepted April 6, 2015.